<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Eli Lilly (LLY) Announces Promising Results For Jaypirca In CLL Phase 3 Trial</title>
    <meta name="description" content="Pharmaceuticals industry, which had an 11.5% decline.; market, which gained 20.8% over the past year, and the U.S.; This announcement likely played a key role in the company’s 16% share price rise over the past month." />
    <link rel="alternate" type="application/rss+xml" title="Daily Finance Newsletter" href="https://suavir600.github.io/newsletter/feed.xml" />
    <style>
:root{--bg:#0b0f19;--fg:#e8ecf2;--muted:#93a1b1;--card:#121826;--accent:#4f8cff}
*{box-sizing:border-box} body{margin:0;background:var(--bg);color:var(--fg);font:16px/1.55 system-ui,-apple-system,Segoe UI,Roboto,Ubuntu}
a{color:var(--accent);text-decoration:none} a:hover{text-decoration:underline}
.container{max-width:980px;margin:0 auto;padding:20px}
.nav{display:flex;align-items:center;justify-content:space-between;margin-bottom:20px}
.brand{font-weight:700} .muted{color:var(--muted)}
.grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(280px,1fr));gap:16px}
.card{background:var(--card);border-radius:16px;padding:16px;box-shadow:0 6px 20px rgba(0,0,0,.25)}
.card h3{margin:0 0 8px 0;font-size:1.05rem}
.badge{display:inline-block;background:#1c2335;color:#c0cad8;padding:.2rem .5rem;border-radius:999px;font-size:.75rem;margin-right:.4rem}
.btn{display:inline-block;background:var(--accent);color:#fff;padding:.5rem .75rem;border-radius:10px;font-weight:600}
.btn-outline{background:transparent;border:1px solid var(--accent);color:var(--accent)}
.list ul{margin:.5rem 0 0 1.2rem}
.footer{margin-top:36px;color:var(--muted);font-size:.9rem;text-align:center}
hr{border:none;border-top:1px solid #223; margin:16px 0}
</style>
  </head>
  <body>
    <div class="container">
      <div class="nav">
        <div class="brand"><a href="https://suavir600.github.io/newsletter">Daily Finance Newsletter</a></div>
        <div class="muted">5–7 key bullets per story</div>
      </div>
      
<h1>Eli Lilly (LLY) Announces Promising Results For Jaypirca In CLL Phase 3 Trial</h1>
<div class="muted">2025-09-08 17:25:58+00:00</div>
<hr />
<div class="list"><ul>
  <li>Pharmaceuticals industry, which had an 11.5% decline.</li><li>market, which gained 20.8% over the past year, and the U.S.</li><li>This announcement likely played a key role in the company’s 16% share price rise over the past month.</li><li>Over the past five years, Eli Lilly&#x27;s total shareholder return, inclusive of share price appreciation and dividends, reached 416.18%, demonstrating significant longer-term performance.</li><li>Currently, the company&#x27;s shares trade at US$727.21, showing a considerable discount to the consensus price target of US$891.62, indicating potential room for upward correction should these growth drivers effectively mate</li><li>We&#x27;ve spotted 2 weaknesses for Eli Lilly you should be aware of, and 1 of them is a bit unpleasant.</li><li>This article by Simply Wall St is general in nature.</li>
</ul></div>
<div style="margin-top:12px">
  <a class="btn-outline" href="https://finance.yahoo.com/news/eli-lilly-lly-announces-promising-172558054.html" target="_blank" rel="noopener">Original</a>
  <a class="btn" href="https://twitter.com/intent/tweet?text=Eli+Lilly+%28LLY%29+Announces+Promising+Results+For+Jaypirca+In+CLL+Phase+3+Trial%0A%E2%80%A2+Pharmaceuticals+industry%2C+which+had+an+11.5%25+decline.%0A%E2%80%A2+market%2C+which+gained+20.8%25+over+the+past+year%2C+and+the+U.S.%0A%E2%80%A2+This+announcement+likely+played+a+key+role+in+the+compan%E2%80%A6%0Ahttps%3A%2F%2Fsuavir600.github.io%2Fnewsletter%2Farticles%2Feli-lilly-lly-announces-promising-results-for-jaypirca-in-cll-phase-3-trial%2F" target="_blank" rel="noopener">Share on X</a>
</div>

      <div class="footer">© 2025 · Built from digest_5bullets.md</div>
    </div>
  </body>
</html>